World’s largest electric truck in
The eDumper dump truck is the largest electric vehicle in the world and will be in operation in a quarry in Péry in the Bernese Jura from 20 April.

EPFL part of international effort to create Human Cell Atlas
In its first investment in EPFL, the Chan Zuckerberg Initiative (CZI) and DAF, an advised fund of Silicon Valley Community Foundation, have awarded a research grant to the lab of Professor Bart Depla

How Do People Die in Switzerland Today?
Across all regions, in more than three quarters of cases deaths were preceded by at least one end-of-life decision. (Image: Istock.com/LPETTET) Today, almost two thirds of deaths in Switzerland are foreseeable due to old age or terminal illness. This means that difficult end-of-life decision have to be made.

Art from the lab: the beauty of science

FORWARD Forum: a unique gathering in support of innovation in SMEs
EPFL, PME Magazine and Le Temps are hosting a new type of forum aimed at supporting innovation in Swiss small and medium-sized businesses (SMEs).

Hydrogen as a pedalling aid
An e-bike fueled with hydrogen instead of electricity? No, this is not a utopia, but reality: industrial gas specialist Linde has developed a hydrogen pedelec equipped with a compact fuel cell instead of the usual battery. Florian Freund was inspired by the invention for his Matura thesis: He developed a prototype with which the hydrogen e-bike can be refuelled safely at the H 2 filling station on the Empa mobility demonstrator move.

Novartis renews commitment to malaria elimination, investing USD 100 million to research and develop next-generation antimalarials
Company to invest more than USD 100 million to advance research and development of new antimalarials over the next five years   Commitment includes expanding access to pediatric antimalarials and imp

Novartis presents first-of-its-kind evidence at AAN reinforcing robust and consistent efficacy of AimovigTM* (erenumab) for migraine patients with multiple treatment failures
Novartis presents first-of-its-kind evidence at AAN reinforcing robust and consistent efficacy of AimovigTM* (erenumab) for migraine patients with multiple treatment failures The LIBERTY trial studie

Novartis announces new analysis demonstrating Entresto helped preserve kidney function in patients with chronic heart failure, especially those with diabetes
Novartis announces new analysis demonstrating Entresto helped preserve kidney function in patients with chronic heart failure, especially those with diabetes Heart failure (HF) patients with reduced

Continuing education - customised and connected to business

Europe’s urban mine
In January 2018 the first pan-European database for secondary raw materials, including many "critical" ones, went online. Ever since, we have known more about which raw material depots reside in cars, batteries and electronic devices sold, used and stored in the 28 EU countries - and ultimately recycled or disposed of.

Joint Exhibition with Ugandan Museums

Five proposals win initial "catalyst" funding
Researchers from Campus Biotech were invited to develop joint projects with partner research institutes and bid for funding from the Bertarelli Foundation.

EPFL wins the International Physicists' Tournament

A major success at the European level
Ten professors from ETH Zurich - two of them female, and eight male - have secured prestigious ERC Advanced Grants.

Researcher Granted EUR 2.5 Million in Funding
Each year the European Research Council (ERC), open to both junior and established researchers, awards substantial funding for outstanding fundamental research.

Earthquake engineering: an EPFL laboratory stands out
Three researchers from the Resilient Steel Structures Laboratory (RESSlab) beat 11 other teams to win an international computer simulation contest on earthquake engineering.

The fight for clean emissions continues
It is exactly 20 years since experts from Empa and VERT published the first test results on diesel particle filters.

Sandoz outlines plans for next Healthcare Access Challenge (HACk), to support local digital innovation
Sandoz White Paper outlines importance of digital solutions to specific local healthcare problems, as part of approach to increasing access to healthcare Publication, which coincides with World Healt

Novartis announces JAMA Cardiology publication of data showing Entresto improves physical and social activity in HFrEF patients versus enalapril
Novartis announces JAMA Cardiology publication of data showing Entresto improves physical and social activity in HFrEF patients versus enalapril Post-hoc analysis of PARADIGM-HF published in JAMA Car

Enhanced therapeutic vaccine platform achieves two proof of concepts in veterinary medical use
Chronical allergic diseases of dogs and horses can now be treated with an innovative vaccine. It was developed by an international research team led by he University of Bern and in cooperation with the University of Zurich, together with private enterprise companies. The findings obtained in horses and dogs could lead to similar herapeutic vaccines for humans.

Europe’s University Leaders Meet at UZH

Therapeutic vaccine platform achieves proof of concepts in veterinary medical use
Scientists from the Universities of Bern, Zurich and Oxford as well as the Latvian Biomedical Research & Study Centre led by Prof. Martin F. Bachmann (University Clinic of Rheumatology, Immunoloy and Allergology, University of Bern) have developed a new therapeutic vaccine technology based upon enhanced virus like nanoparticle conjugates.

An EPFL startup raises 20 million francs
Abionic, an EPFL spin-off, has just brought in 20 million francs in its third funding round. The company's rapid allergy test can now be used to detect sepsis as well.

Novartis to present predictability data for brolucizumab in nAMD from pivotal HAWK and HARRIER trials at ARVO
Novartis will present new data from the HAWK and HARRIER Phase III trials at the upcoming Association for Research in Vision and Ophthalmology (ARVO) 2018 Annual Meeting, Honolulu, April 29 - May 3.

Phase III data in The Lancet show Novartis siponimod significantly improves outcomes in patients with secondary progressive MS
EXPAND shows oral siponimod (BAF312) is the first potential therapy to meaningfully delay disability progression in typical secondary progressive MS (SPMS) patients   Results demonstrate siponimod al

Novartis drug Tasigna approved by FDA to treat children with rare form of leukemia
Tasigna (nilotinib) approved for pediatric patients with newly diagnosed Ph+ CML-CP and children with Ph+ CML-CP resistant or intolerant to prior TKI therapy   New indication approved under FDA Prior

Robotic collaboration in timber construction
Researchers from ETH Zurich are using a new method for digital timber construction in a real project for the first time.

North and South Cooperation to Combat Tuberculosis
More than 4,000 people worldwide die from tuberculosis every day. This means the disease tops the list of the most common causes of death that result from a single pathogen.

Andrej Trauner Wins Swiss TB Award
Tuberculosis still kills 1.7 million people annually and the rate of resistance against current treatments continues to increase.

New Anti-Cancer Protein
An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver.

Professorship for Empa researcher

NEST unit nominated for architecture

Phase III IMpower131 study showed Roche’s TECENTRIQ (atezolizumab) plus chemotherapy (carboplatin and Abraxane) reduced the risk of disease worsening or death in the initial treatment of people with a type of advanced squamous lung cancer
Phase III IMpower131 study showed Roche's TECENTRIQ (atezolizumab) plus chemotherapy (carboplatin and Abraxane) reduced the risk of disease worsening or death in the initial treatment of people with

Paraplegic rats walk again after therapy, now we know why
Paraplegic rats walk again in response to neuroprosthetic rehabilitation that allows the brain to elaborate new routes so that motor commands about walking, swimming and even climbing staircases reach spinal cord execution centers below the injury. With the help of robot-assisted rehabilitation and electrochemical spinal cord stimulation, rats with clinically-relevant spinal cord injury regain control of their otherwise paralyzed limbs.

LSD Blurs Boundaries between the experience of Self and Other
Virtually all mental health disorders come with difficulties in interpersonal relations that in the long run negatively affect the progression of the disease. The associated health an social restrictions can only be marginally improved by current forms of therapy. One of the reasons for this is that there has been very little research into the basic neurobiological principles and in particular the neurochemical mechanisms of these kinds of disorders.

National Health Promotion Day in Moldova